Syra Health Corp. Class A Common Stock carries a market capitalization of 9.91M, placing it among publicly traded companies globally. Its enterprise value stands at 7.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.91M |
| Enterprise Value | 7.07M |
Syra Health Corp. Class A Common Stock currently has 14.19M shares outstanding.
| Shares Outstanding | 14.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Syra Health Corp. Class A Common Stock trades at a trailing price-to-earnings ratio of 58.21. The price-to-sales ratio is 0.94, and the price-to-book ratio stands at 3.43.
| PE Ratio | 58.21 |
| PS Ratio | 0.94 |
| PB Ratio | 3.43 |
| P/TBV Ratio | 3.43 |
| P/FCF Ratio | 70.96 |
| P/OCF Ratio | 69.39 |
On an enterprise value basis, Syra Health Corp. Class A Common Stock trades at an EV/EBITDA multiple of 83.97 and an EV/FCF ratio of 58.61. The EV/Sales ratio of 0.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 94.63 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.87 |
| EV / EBITDA | 83.97 |
| EV / EBIT | 94.63 |
| EV / FCF | 58.61 |
Syra Health Corp. Class A Common Stock maintains a current ratio of 3.13, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.67, indicating elevated leverage, while an interest coverage ratio of 7.75 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.13 |
| Quick Ratio | 3.00 |
| Debt / Equity | 5.67 |
| Debt / EBITDA | 1.77 |
| Interest Coverage | 7.75 |
Syra Health Corp. Class A Common Stock posts a return on equity of 5.18 and a return on invested capital of 2.82.
| Return on Equity (ROE) | 5.18 |
| Return on Assets (ROA) | 3.58 |
| Return on Invested Capital (ROIC) | 2.82 |
| Return on Capital Employed (ROCE) | 5.34 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Syra Health Corp. Class A Common Stock's stock has gained approximately 978.18182% over the past 52 weeks. The 50-day moving average sits at 0.87, while the 200-day moving average is 0.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | 978.18182% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 0.49 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Syra Health Corp. Class A Common Stock generated 8.09M in revenue and converted that into 130,749.00 in net income, yielding earnings per share of 0.01. EBITDA reached 84,210.00, while operating income came in at 74,722.00.
| Revenue | 8.09M |
| Gross Profit | 3.18M |
| Operating Income | 74,722.00 |
| Pretax Income | 130,749.00 |
| Net Income | 130,749.00 |
| EBITDA | 84,210.00 |
| EBIT | 74,722.00 |
| Earnings Per Share (EPS) | 0.01 |
Syra Health Corp. Class A Common Stock holds 2.12M in cash and equivalents against 149,338.00 in total debt, resulting in a net debt position of -2.05M. Total book value stands at 2.63M, with working capital of 2.55M providing operational flexibility.
| Cash & Cash Equivalents | 2.12M |
| Total Debt | 149,338.00 |
| Net Debt | -2.05M |
| Equity (Book Value) | 2.63M |
| Book Value Per Share | 0.19 |
| Working Capital | 2.55M |
Syra Health Corp. Class A Common Stock produced 109,683.00 in operating cash flow over the past twelve months. After subtracting -107.00 in capital expenditures, free cash flow totaled 109,576.00 - equivalent to 0.01 per share.
| Operating Cash Flow | 109,683.00 |
| Capital Expenditures | -107.00 |
| Free Cash Flow | 109,576.00 |
| FCF Per Share | 0.01 |
Syra Health Corp. Class A Common Stock operates with a gross margin of 39.35, reflecting its pricing power and cost economics. The operating margin of 0.92 and net profit margin of 1.62 provide insight into operational efficiency.
| Gross Margin | 39.35 |
| Operating Margin | 0.92 |
| Pretax Margin | 1.62 |
| Profit Margin | 1.62 |
| EBITDA Margin | 1.04 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 3.23 |
| FCF Yield | 1.41 |
Syra Health Corp. Class A Common Stock posts an Altman Z-Score of 4.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.14 |